Outset Medical, Inc.: diluted earnings per share
Diluted earnings per share for Outset Medical, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Outset Medical, Inc. financial histories
What this measure means
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
Exact concept: us-gaap:EarningsPerShareDiluted. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Reading these values
This selected numerical history matches Basic earnings per share for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Context from the filing
For Outset Medical in 2023–2025, awards under its equity compensation plan and warrants are excluded from diluted loss per share as anti-dilutive during losses. This review covers only reported USD EPS. The separate weighted-average share observations remain withheld because their inline tags conflict with the statement’s thousands heading. No scaling, split adjustment or EPS recomputation is applied to resolve that share-count conflict. Read the source filing.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -5.37 | USD/shares | 2026-02-13 | 10-K · 0001193125-26-051278 |
| 2024-01-01 | 2024-12-31 | -36.96 | USD/shares | 2026-02-13 | 10-K · 0001193125-26-051278 |
| 2023-01-01 | 2023-12-31 | -52.28 | USD/shares | 2026-02-13 | 10-K · 0001193125-26-051278 |
| 2022-01-01 | 2022-12-31 | -3.38 | USD/shares | 2025-02-28 | 10-K · 0000950170-25-030045 |
| 2021-01-01 | 2021-12-31 | -2.89 | USD/shares | 2024-02-21 | 10-K · 0000950170-24-018093 |
| 2020-01-01 | 2020-12-31 | -4.85 | USD/shares | 2023-02-13 | 10-K · 0000950170-23-002648 |
Related financial histories
- Outset Medical, Inc.: total assets
- Outset Medical, Inc.: total liabilities
- Outset Medical, Inc.: stockholders equity
- Outset Medical, Inc.: cash and cash equivalents
- Outset Medical, Inc.: net income or loss
- Outset Medical, Inc.: operating cash flow
- Outset Medical, Inc.: capital expenditure payments
- Outset Medical, Inc.: contract revenue excluding tax
- Outset Medical, Inc.: financing cash flow
- Outset Medical, Inc.: investing cash flow
- Outset Medical, Inc.: retained earnings or deficit
- Outset Medical, Inc.: basic weighted-average shares
- Outset Medical, Inc.: diluted weighted-average shares
- Outset Medical, Inc.: basic earnings per share
- Outset Medical, Inc.: income tax expense or benefit
- Outset Medical, Inc.: net property, plant and equipment
- Outset Medical, Inc.: share-based compensation expense
- Outset Medical, Inc.: operating income or loss
- Outset Medical, Inc.: current assets
- Outset Medical, Inc.: interest expense
- Outset Medical, Inc.: current liabilities
- Outset Medical, Inc.: current accounts payable
- Outset Medical, Inc.: net current accounts receivable
- Outset Medical, Inc.: operating expenses
- Outset Medical, Inc.: net inventory
- Outset Medical, Inc.: gross profit
- Outset Medical, Inc.: research and development expense
Inspect the source
- Entity
- Outset Medical, Inc. / CIK 0001484612
- Captured
- 2026-09-20T09:09:18.471Z
- SEC response SHA-256
02af597b3235cdde453b8e191f935ab9286843fac1669b188d8e36c1d501f70c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001484612.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))